Free Trial

Denali Therapeutics (DNLI) SEC Filings & 10K Form

Denali Therapeutics logo
$16.44 +0.38 (+2.37%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$16.43 -0.01 (-0.03%)
As of 05/2/2025 07:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Denali Therapeutics SEC Filings

DateFilerForm TypeView
04/17/2025
3:05 PM
Denali Therapeutics (Filer)
Form DEF 14A
04/17/2025
3:06 PM
Denali Therapeutics (Filer)
Form DEFA14A
04/17/2025
3:07 PM
Denali Therapeutics (Filer)
Form ARS
04/17/2025
2:05 PM
BlackRock, Inc. (Filed by)
Denali Therapeutics (Subject)
Form SCHEDULE 13G/A
04/02/2025
7:02 AM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2025
4:26 PM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
3:11 PM
Denali Therapeutics (Filer)
Form S-3ASR
02/27/2025
3:12 PM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
3:13 PM
Denali Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/13/2025
1:14 PM
Capital Research Global Investors (Filed by)
Denali Therapeutics (Subject)
Form SCHEDULE 13G/A
02/12/2025
9:52 AM
BAILLIE GIFFORD & CO (Filed by)
Denali Therapeutics (Subject)
Form SCHEDULE 13G/A
01/13/2025
7:03 AM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
7:23 PM
Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:24 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:25 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:26 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
7:01 PM
Denali Therapeutics (Subject)
Ho Carole (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
7:03 PM
Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
7:06 PM
Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
7:08 PM
Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
7:10 PM
Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
7:12 PM
Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
7:14 PM
Denali Therapeutics (Subject)
Ho Carole (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
5:56 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
5:57 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
5:59 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:17 PM
Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/31/2024
3:18 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
3:44 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
4:19 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
8:55 AM
Denali Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
11/08/2024
9:52 AM
Denali Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
11/07/2024
3:39 PM
Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/22/2024
3:30 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2024
3:11 PM
BlackRock, Inc. (Filed by)
Denali Therapeutics (Subject)
Form SC 13G/A
10/18/2024
3:19 PM
Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2024
3:37 PM
Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
3:25 PM
Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2024
3:25 PM
Denali Therapeutics (Subject)
SATO VICKI L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
5:26 PM
Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:14 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Shocking AI play that’s beats Nvidia by a country mile (Ad)

You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is about to announce could change the AI market once again. Experts already predict the total addressable market could climb past $20 trillion. But Sykes believes most investors have missed what’s coming next. He’s tracking a new shift — and says the biggest gains are still ahead.

Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave.
08/22/2024
3:14 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:15 PM
Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:16 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
3:40 PM
Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2024
3:42 PM
Denali Therapeutics (Subject)
Ho Carole (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
7:08 PM
Denali Therapeutics (Subject)
Ho Carole (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
7:08 PM
Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
7:09 PM
Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
7:09 PM
Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
3:27 PM
Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2024
12:18 PM
Denali Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G
08/15/2024
3:10 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
7:36 PM
Denali Therapeutics (Subject)
Ho Carole (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2024
7:37 PM
Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2024
5:52 AM
Denali Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2024
5:48 AM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2024
8:13 PM
Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
8:13 PM
Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
3:38 PM
Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/01/2024
3:43 PM
Denali Therapeutics (Subject)
SATO VICKI L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2024
7:06 PM
Cook Jennifer E. (Reporting)
Denali Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
5:31 PM
Denali Therapeutics (Issuer)
Tessier-Lavigne Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
5:32 PM
Denali Therapeutics (Issuer)
Thornberry Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
5:33 PM
Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
5:20 PM
Denali Therapeutics (Issuer)
Klein Peter S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
5:27 PM
Denali Therapeutics (Issuer)
Harris Erik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
5:28 PM
Denali Therapeutics (Issuer)
FLATLEY JAY T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
5:29 PM
Denali Therapeutics (Issuer)
Schenkein David P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
5:30 PM
Cook Jennifer E. (Reporting)
Denali Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
5:30 PM
Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
3:01 PM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:DNLI) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners